New Hampshire sues OxyContin manufacturer over marketing tactics

Listen
Text
  • Small
  • Medium
  • Large

New Hampshire filed a lawsuit against Stamford, Conn.-based Purdue Pharma LP for allegedly misleading marketing campaigns, which state officials believe fueled their current opioid epidemic, according to Reuters.

The suit alleges that Purdue did not accurately represent the addictive qualities of OxyContin in their marketing campaigns and overstated the benefits of using opioids to treat chronic pain. It is still unknown what kinds of damages New Hampshire is seeking.

 "We share New Hampshire officials' concerns about the opioid crisis and we are committed to working collaboratively to find solutions," Purdue said in a statement, though they denied any wrongdoing.

More Articles on Opioids:

Opioid overdose deaths could be higher than CDC numbers indicate, study finds 
Physicians from lower-tier med schools prescribe more opioids 
Insys Therapeutics may settle Illinois opioid lawsuit for up to $4.5M: 5 things to know

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars